Equity Profile

IRTC

iRhythm Holdings, Inc.

Health CareHealth Care Equipment$3.9B

Jul30Thu

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

iRhythm Holdings, Inc. operates in the health care sector, specializing in innovative cardiac monitoring solutions....

Key Metrics to Watch

EPS (Earnings Per Share)

EPS is a key indicator of the company's profitability and will show how well iRhythm is managing its costs and generating revenue.

N/A

Revenue Growth

Revenue growth is crucial to assess the company's ability to expand its market share and improve financial health.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

IRTC Q2-2026 Earnings Preview

Context

Company Snapshot

iRhythm Holdings, Inc. operates in the health care sector, specializing in innovative cardiac monitoring solutions. The company’s technology helps diagnose heart conditions, which is increasingly important as the population ages and the demand for remote health monitoring grows.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+209.31%

Avg Stock Reaction

+0.87%

Last Quarter Recap

In Q1 2026, iRhythm reported an EPS of -$0.35, which was better than analysts' expectations of -$0.56, resulting in a positive stock reaction. However, revenue figures were not disclosed, leaving some uncertainty about overall performance.

Management Promises & Guidance

Focus on expanding customer base.
Commitment to improving product offerings.
Plans to enhance operational efficiency.

Expectations

Wall Street Expectations

Investors are cautiously optimistic about iRhythm's upcoming earnings, especially given the company's recent ability to exceed EPS expectations. However, there is uncertainty surrounding revenue growth and customer acquisition.

Bull Case

If iRhythm continues to beat EPS estimates and shows strong revenue growth, it could indicate robust demand for its products, potentially driving the stock higher.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to a decline in investor confidence and negatively impact the stock.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the expected revenue growth for the upcoming quarter?

Revenue growth will be a critical indicator of the company's market demand and operational success, influencing investor sentiment.

How many new customers were added in the last quarter?

Customer acquisition is vital for sustaining growth and profitability, and any significant changes could impact future earnings.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for iRhythm to significantly expand its customer base, especially in light of recent technological advancements in cardiac monitoring.

Supporting Evidence

Historical EPS surprises indicate a strong ability to outperform expectations.

The options market suggests a higher-than-average anticipated move, indicating investor uncertainty.

Recent trends in health care technology adoption could favor iRhythm's innovative solutions.

Key Risk

If customer growth exceeds expectations, it could lead to a reevaluation of the company's growth potential.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core debate this quarter revolves around whether iRhythm can maintain its growth trajectory in a competitive health care market.

Bull Confirmed If

A revenue growth rate of over 20% year-over-year would confirm strong demand and operational success.

Bear Confirmed If

If revenue growth is below 5%, it would raise concerns about market competitiveness and demand.

Pre-Earnings Positioning

Options Market

Implied Move

±3.3%

Historical Avg

±2.1%

Pricing rich

The options market is pricing in a potential move of about 3.3%, suggesting that investors are anticipating some volatility around the earnings announcement.

Options are pricing ±3.3% while IRTC has averaged ±2.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

48.4%

Calls (1K)P/C Ratio: 0.30Puts (1K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If iRhythm beats expectations, history suggests a potential stock increase of around 1.17%, confirming strong operational performance.

In-Line / Cautious

If results are in line but cautious, the stock may see muted reactions as investors reassess future growth prospects.

Miss

A miss could lead to a slight decline in stock price, with historical data showing minimal movement in such cases.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Details on new customer acquisition numbers.
2Any updates on product development and enhancements.
3Insights into market competition and positioning.
4Management's outlook on future revenue growth.
5Responses to any regulatory changes affecting the health care sector.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Jul27

KRCAMC

Kilroy Realty Corporation

PreviewView

Jul27

PIIAMC

Company Snapshot

iRhythm Holdings, Inc. operates in the health care sector, specializing in innovative cardiac monitoring solutions....

Key Metrics to Watch

EPS (Earnings Per Share)

EPS is a key indicator of the company's profitability and will show how well iRhythm is managing its costs and generating revenue.

N/A

Revenue Growth

Revenue growth is crucial to assess the company's ability to expand its market share and improve financial health.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

IRTC Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+209.31%

Avg Stock Reaction

+0.87%

Last Quarter Recap

Management Promises & Guidance

Focus on expanding customer base.
Commitment to improving product offerings.
Plans to enhance operational efficiency.

Expectations

Wall Street Expectations

Bull Case

If iRhythm continues to beat EPS estimates and shows strong revenue growth, it could indicate robust demand for its products, potentially driving the stock higher.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to a decline in investor confidence and negatively impact the stock.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the expected revenue growth for the upcoming quarter?

Revenue growth will be a critical indicator of the company's market demand and operational success, influencing investor sentiment.

How many new customers were added in the last quarter?

Customer acquisition is vital for sustaining growth and profitability, and any significant changes could impact future earnings.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for iRhythm to significantly expand its customer base, especially in light of recent technological advancements in cardiac monitoring.

Supporting Evidence

Historical EPS surprises indicate a strong ability to outperform expectations.

The options market suggests a higher-than-average anticipated move, indicating investor uncertainty.

Recent trends in health care technology adoption could favor iRhythm's innovative solutions.

Key Risk

If customer growth exceeds expectations, it could lead to a reevaluation of the company's growth potential.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core debate this quarter revolves around whether iRhythm can maintain its growth trajectory in a competitive health care market.

Bull Confirmed If

A revenue growth rate of over 20% year-over-year would confirm strong demand and operational success.

Bear Confirmed If

If revenue growth is below 5%, it would raise concerns about market competitiveness and demand.

Pre-Earnings Positioning

Options Market

Implied Move

±3.3%

Historical Avg

±2.1%

Pricing rich

The options market is pricing in a potential move of about 3.3%, suggesting that investors are anticipating some volatility around the earnings announcement.

Options are pricing ±3.3% while IRTC has averaged ±2.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

48.4%

Calls (1K)P/C Ratio: 0.30Puts (1K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If iRhythm beats expectations, history suggests a potential stock increase of around 1.17%, confirming strong operational performance.

In-Line / Cautious

If results are in line but cautious, the stock may see muted reactions as investors reassess future growth prospects.

Miss

A miss could lead to a slight decline in stock price, with historical data showing minimal movement in such cases.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Details on new customer acquisition numbers.
2Any updates on product development and enhancements.
3Insights into market competition and positioning.
4Management's outlook on future revenue growth.
5Responses to any regulatory changes affecting the health care sector.